Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hallucinogens”

161 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 161 results

Not applicableActive Not RecruitingNCT07717866
What this trial is testing

Trifecta Research Study

Who this might be right for
PTSD - Post Traumatic Stress DisorderCognitive DysfunctionBrain Injury+2 more
Axial Therapeutic Research 52
Early research (Phase 1)Study completedNCT05698095
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers

Who this might be right for
PharmacokineticsSafetyTolerability
Usona Institute 54
Early research (Phase 1)Looking for participantsNCT05866471
What this trial is testing

The ENHANCE Study: taVNS and Psilocybin

Who this might be right for
HealthyPsychedelic ExperiencesVagus Nerve Stimulation
University of Wisconsin, Madison 108
Very early researchWithdrawnNCT05252598
What this trial is testing

Mood and Cognitive Effects of Psilocybin in Healthy Participants

Who this might be right for
Mood DisturbanceMood ChangeSleep Disturbance+7 more
Optimi Health Corporation
Testing effectiveness (Phase 2)Study completedNCT06816667
What this trial is testing

Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety

Who this might be right for
Healthy Volunteers
Biomind Labs Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07211438
What this trial is testing

Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression

Who this might be right for
Treatment-Resistant Depression
Centre for Addiction and Mental Health 40
Not applicableStudy completedNCT05042765
What this trial is testing

Entheogen Resurgence

Who this might be right for
Psychedelic Experiences
Vireo Health 102
Early research (Phase 1)Ended earlyNCT04424225
What this trial is testing

Visual Surround Suppression and Perceptual Expectation Under Psilocybin

Who this might be right for
Perception DisturbanceVisual SuppressionPsychedelic Experiences
University of Minnesota 10
Large-scale testing (Phase 3)Study completedNCT05163496
What this trial is testing

Frontline Clinician Psilocybin Study

Who this might be right for
Burnout, CaregiverBurnout, ProfessionalCOVID-19+3 more
University of Washington 30
Very early researchLooking for participantsNCT04123314
What this trial is testing

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Who this might be right for
Depressive SymptomsDepressionAlzheimer Disease+1 more
Johns Hopkins University 20
Testing effectiveness (Phase 2)UnknownNCT05709353
What this trial is testing

MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder

Who this might be right for
PTSDAlcohol Use DisorderAlcohol Dependence+2 more
University of Sydney 120
Early research (Phase 1)Active Not RecruitingNCT06299319
What this trial is testing

Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD

Who this might be right for
Obsessive-Compulsive Disorder
Centre for Addiction and Mental Health 10
Early research (Phase 1)Study completedNCT07710027
What this trial is testing

Identification of a Safe and Non-Psychedelic Dose of Psilocybin

Who this might be right for
Healthy Controls
Diamond Therapeutics Inc. 56
Testing effectiveness (Phase 2)Study completedNCT06746441
What this trial is testing

Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers

Who this might be right for
Major Depressive Disorder
Khyber Medical University Peshawar 60
Testing effectiveness (Phase 2)Study completedNCT04141501
What this trial is testing

Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients

Who this might be right for
Alcohol Use Disorder
University of Zurich 37
Early research (Phase 1)Study completedNCT05592379
What this trial is testing

Consciousness, Psilocybin, and Well-Being

Who this might be right for
HealthyPsychedelic ExperiencesSleep
University of Wisconsin, Madison 6
Early research (Phase 1)Looking for participantsNCT07053917
What this trial is testing

Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

Who this might be right for
StrokeChronic StrokeIntracerebral Haemorrhage+9 more
Johns Hopkins University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05554094
What this trial is testing

Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder

Who this might be right for
PTSDStress Disorders, TraumaticStress Disorders, Post-Traumatic+2 more
Ohio State University 15
Testing effectiveness (Phase 2)Looking for participantsNCT06969170
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

Who this might be right for
Generalized Anxiety Disorder (GAD)
Claudio N Soares 50
Early research (Phase 1)Looking for participantsNCT07386730
What this trial is testing

Psychedelics in Healthy Older Adults With Low Well-being

Who this might be right for
Anhedonia in Healthy VolunteersOlder Adults (50-90 Years)
Jennifer Mitchell 80
Next Page